Secular volume decline of 3-5% annually in combustibles as smoking rates fall globally, requiring continuous pricing increases to maintain revenue
Regulatory intensification including menthol bans (implemented in EU/UK), plain packaging expansion, flavor restrictions on NGP, and potential nicotine reduction mandates
Litigation risk from health-related lawsuits, particularly in emerging markets where legal frameworks are evolving
NGP transition risk - uncertainty around consumer adoption of vapor/heated tobacco and profitability timeline, with significant R&D and marketing investment required
Market share pressure from Philip Morris International and British American Tobacco, both with stronger NGP portfolios (IQOS, Vuse) and greater scale
Illicit trade competition in high-tax markets (UK, Australia, France) eroding legal market volumes by 5-10%
Private label and discount segment growth during inflationary periods, pressuring premium brand volumes
Elevated leverage at 2.07x debt/equity with estimated £9B+ net debt requiring £400-500M annual interest expense, limiting financial flexibility
Pension obligations in UK and other European markets creating unfunded liabilities (common for legacy UK industrials)
Currency translation risk with ~60% of revenue outside UK but Sterling reporting, creating earnings volatility from GBP strength
Dividend sustainability concerns if FCF declines - current payout requires £2.5-3B annually, representing 65-80% of FCF
StructuralCompetitiveBalance Sheet